The enactment of laws regulating the use of cannabis by adults is associated with short-term declines in self-reported marijuana use by young people, according to findings published today in the journal JAMA Pediatrics.
The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. Commenting on the study’s findings, NORML Deputy Director Paul Armentano said, “These conclusions add to the growing body of evidence that cannabis and its constituents represent an exit away from the use or abuse of other controlled substances rather than a supposed ‘gateway.'”
NORML has submitted written comments to the US Food and Drug Administration ahead of the agency’s scheduled hearing on the regulation CBD-infused products. The agency will be taking in person public testimony on Friday, May 31, with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products.
Marijuana grown by the University of Mississippi for clinical research purposes is genetically divergent from strains of cannabis commercially available in retail markets, according to an analysis prepared by researchers at the University of Northern Colorado.
Newly appointed US Attorney General William Barr is being urged to review more than two-dozen pending applications for federal marijuana grow licenses which have languished before the agency for over two years.
Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act, to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.
Representatives Lou Correa (D-CA) and Clay Higgins (R-LA) and Senators Jon Tester (D-MT) and Dan Sullivan (R-AK) have introduced legislation, HR 712 / S. 179: The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans.
A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis.
Reps. Tulsi Gabbard (HI-02) and Carlos Curbelo (FL-26) led a group of bipartisan lawmakers in introducing The Marijuana Data Collection Act. The act calls upon the National Academy of Sciences (NAS) to collect and synthesize relevant data and to generate a formal report to Congress quantifying the impact of statewide marijuana legalization on matters specific to public health, safety, the economy, and criminal justice, among other issues.